When did BioPlus Acquisition IPO?

BioPlus Acquisition (BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at $10.00 per share. Cantor served as the underwriter for the IPO.

NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free BIOS Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.79
▼
$10.80
50-Day Range: $10.75
▼
$10.84
52-Week Range: $10.05
▼
$11.68

Volume: 5,600 shs
Average Volume: 122,781 shs
Market Capitalization: $209.20 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get BioPlus Acquisition alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About BioPlus Acquisition Stock (NASDAQ:BIOS)

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

BIOS Stock News Headlines

April 16, 2024 | markets.businessinsider.com

Imugene and Kincell Bio Announce Strategic Manufacturing and Process Development Partnership

April 3, 2024 | benzinga.com

Louis G Lange's Net Worth

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

February 9, 2024 | msn.com

Why Intelligent Bio Solutions Stock Is Ripping Higher

January 22, 2024 | investing.com

BioPlus Co Ltd (099430)

October 4, 2023 | msn.com

SPAC BioPlus, Avertix terminate merger; BioPlus to liquidate

October 4, 2023 | markets.businessinsider.com

Avertix, BIOS Acquisition Agree To Terminate Merger Deal

October 4, 2023 | finance.yahoo.com

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

October 4, 2023 | finance.yahoo.com

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

August 16, 2023 | finance.yahoo.com

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

August 16, 2023 | finance.yahoo.com

Avertix Partners with Institute on Implantable Heart Attack Detection System

July 20, 2023 | finance.yahoo.com

Avertix Medical Welcomes Renown Cardiologist to Board of Directors

July 17, 2023 | finance.yahoo.com

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors

June 13, 2023 | finance.yahoo.com

Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando

May 26, 2023 | seekingalpha.com

BIOS BioPlus Acquisition Corp.

May 5, 2023 | msn.com

SPAC BIOS to merge with cardiac device maker Avertix

May 3, 2023 | finance.yahoo.com

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

March 18, 2023 | money.usnews.com

BioPlus Acquisition Corp - Ordinary Shares - Class A

September 23, 2022 | wsj.com

BioPlus Acquisition Corp. Cl A

September 20, 2022 | finance.yahoo.com

BioPlus Acquisition Corp. (BIOS)

September 3, 2022 | investing.com

BioPlus Acquisition Corp (BIOS)

August 13, 2022 | reuters.com

BioPlus Acquisition Corp

August 10, 2022 | finance.yahoo.com

What Type Of Shareholders Own The Most Number of BioPlus Acquisition Corp. (NASDAQ:BIOS) Shares?

See More Headlines

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Unclassified
Industry: Holding & other investment offices
Sub-Industry: N/A
Current Symbol: NASDAQ:BIOS
CUSIP: N/A
CIK: 1856653
Web: bioplusspac.com
Phone: 212-287-4092
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 19,370,000
Free Float: 14,990,000
Market Cap: $209.20 million
Optionable: Not Optionable
Beta: 0.01

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Jonathan M. N. Rigby MBA (Age 55)
Chairman & Chief Bus. Officer
Mr. R. Ross Haghighat (Age 59)
CEO, CFO & Director

Key Competitors

View All Competitors

BIOS Stock Analysis - Frequently Asked Questions

When did BioPlus Acquisition IPO?: BioPlus Acquisition (BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at $10.00 per share. Cantor served as the underwriter for the IPO.

This page (NASDAQ:BIOS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BioPlus Acquisition (BIOS) Stock Price, News & Analysis

About BioPlus Acquisition Stock (NASDAQ:BIOS)

BIOS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BIOS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info